dc.description.abstract |
Purpose: Non-obstructive azoospermia (NOA), defined as the absence of sperm in the ejaculate due to testicular failure,
is observed in 5% to 15% of infertile men and accounts for two-thirds of azoospermia cases. The management of NOA is
marked by significant controversy and global variation in diagnostic and therapeutic approaches, highlighting the crucial
need for well-designed and standardized clinical practice guidelines. We present comprehensive graded clinical practice
recommendations and statements for diagnosing and treating NOA, aiming to establish standardized strategies that can glob-
ally help guide practitioners in their practice.
Materials and Methods: A comprehensive literature review was conducted to gather evidence on the epidemiological, di-
agnostic, and therapeutic aspects of NOA. The Global Andrology Forum (GAF) recommendations were developed through
the collaboration of a global panel of experts using the Delphi method and surveys to achieve consensus. Statements were
graded according to the Oxford Centre for Evidence-Based Medicine “GRADE” classification as either “Strong” or “Weak.”
Statements receiving at least 80% expert consensus were graded as “Strong,” while others were categorized as “Weak.”
Results: The GAF has formulated a total of 49 recommendations and statements on the diagnosis and treatment of NOA, in-
cluding 21 for diagnosis and 28 for treatment. The recommendations and statements were evaluated and graded by a panel
of 48 GAF experts from 25 countries worldwide. The majority of experts (60.5%) had more than 10 years of clinical experi-
ence in managing NOA.
Conclusions: The GAF guidelines address discrepancies in NOA management across diverse clinical settings and provide
comprehensive graded recommendations to guide clinicians in its diagnosis and treatment. Developed and graded by a large
worldwide panel of experts, the current guidelines present simplified, high-standard strategies that can be seamlessly inte-
grated into the daily global practice, offering practitioners a clear framework for managing NOA. |
en_US |